Drug Profile
Ferric citrate - Akebia Therapeutics
Alternative Names: Auryxia; Ferric citrate dihydrate; Ferric citrate hydrate; Fexeric; JTT-751; KRX-0502; Nephoxil; PBF-1681; Riona; Tetraferric tricitrate decahydrate; ZerenexLatest Information Update: 26 Mar 2024
Price :
$50
*
At a glance
- Originator Panacor Bioscience; Panion & BF Biotech
- Developer Akebia Therapeutics; Japan Tobacco; Panion & BF Biotech; Torii Pharmaceutical
- Class Antianaemics; Ferric compounds; Hyperphosphataemia therapies; Small molecules; Tricarboxylic acids
- Mechanism of Action Phosphate binding modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hyperphosphataemia; Iron deficiency anaemia